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This paper describes the deﬁnition of venous thromboembolism and introduces to personalized venous
thromboembolism risk assessment tools overseas. Thoughts are given on the development, amendment,
application and validation of these tools. The paper provides a reference for building personalized venous
thromboembolism risk assessment tools in China.
© 2016 Shanxi Medical Periodical Press. Publishing services by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The incidence of venous thromboembolism (VTE) is up to
0.0816% in the United States,1 and the incidence of VTE is also
increasing each year in Asian populations.2,3 VTE has become a
public issue that seriously threatens human health and economic
development.4 It is therefore critical to timely perform VTE risk
assessment and undertake VTE prevention in patients.5 Relevant
guidelines6,7 suggest that it is necessary to use VTE risk assessment
models (RAMs) for VTE risk assessment and stratiﬁcation in pa-
tients and to take appropriate preventive measures to reduce the
incidence of VTE. There are numerous studies on VTE RAMs over-
seas, but such research efforts still lack a systematic and effective
system in China. This paper reviews the current state of the science
and advances in research on personalized VTE RAMs overseas to
provide a reference for building personalized VTE RAMs in China.
2. Deﬁnition of VTE
VTE includes deep vein thrombosis (DVT) and pulmonary
thromboembolism (PE). DVT refers to abnormal blood coagulational Periodical Press.
blishing services by Elsevier B.V. Thin a deep vein that blocks the lumen and results in venous reﬂux
disorder.8 Typical symptoms of DVT include swelling, pain, and
even ulcers in the affected limbs. If thrombi detach and reach the
lungs through the circulation, they may block pulmonary arteries
and result in PE. PEs manifest as chest pain, dyspnea, and even
sudden death. This condition is extremely harmful, and 25% of DVT
patients suffer from sudden death due to PE.93. Personalized VTE risk assessment tools overseas
3.1. Caprini RAM
In the late 1980s, Joseph et al from the United States designed
the Caprini VTE RAM based on clinical experience and the results of
existing studies. The Caprini RAM, which has been translated and
published in 12 languages,10,11 includes approximately 40 risk fac-
tors. Each factor is given a score of 1e5 points by which the risk of
VTE for patients is ranked into four grades: low risk (<3 points),
moderate risk (3e4 points), high risk (5e8 points), and extremely
high risk (>8 points); appropriate preventive measures and dura-
tion of therapy are recommended accordingly. Large-sample
retrospective studies demonstrated the feasibility and effective-
ness of the Caprini RAM for preventing VTE in patients.12e14 In
China, retrospective and prospective studies have also shown that
this model is an effective tool to screen high-risk populations foris is an open access article under the CC BY-NC-ND license (http://creativecommons.
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ment in cancer patients was noted in the latest “Guidelines on
Prevention and Treatment of Tumor-associated Venous Thrombo-
embolism in China”. The model has been widely used since it was
developed. The greatest feature of this model is that it comprises
more than 40 speciﬁc risk factors, including objective laboratory
tests, while it also takes into account the effect of special physio-
logical and pathological conditions in women on VTE. The model is
comprehensive, speciﬁc, and highly feasible to use. Study on this
scale is instructive for building VTE RAMs, particularly when VET
risk assessment is still in its infancy in China.3.2. Autar scale
The Autar scale, whichwas designed by Autar in 1996,16 includes
seven risk factors: age, bodymass index (BMI), activity, special risks
(use of contraceptives and pregnancy), trauma, surgery, and high-
risk disease. Each risk factor is given a score of 1e7 points by
which patients are divided into three groups: low risk (7e10 points,
incidence <10%), intermediate risk (11e14 points, incidence 11%e
40%), and high risk (15 points, incidence >40%); the aim is to
provide a simple and convenient VTE assessment scale for para-
medics. Small-sample reliability testing of the model showed a
Pearson coefﬁcient of 0.98, a sensitivity of 100%, and a speciﬁcity of
81%.16 Test-retest reliability evaluation showed a Cronbach's a co-
efﬁcient of 0.88e0.95 and an internal correlation coefﬁcient of
0.94e0.99.17 Additionally, test-retest reliability evaluations showed
a Cronbach's a coefﬁcient of 0.78e0.90.18 These studies indicate
that the Autar scale can appropriately classify the risk of VTE in
patients. This scale is characterized by a detailed division of BMI,
activity, and trauma. In particular, it details the effect of trauma to
different parts of body on the incidence of VTE for common traumas
in surgical patients, which provides a theoretical and practical basis
for the scale's division of trauma.3.3. Risk assessment proﬁle (RAP) score
The RAP score,19 which was designed in 1997, includes four risk
factors: age, underlying diseases, iatrogenic factors, and trauma-
related factors. Each risk factor is given a score of 2e4 points by
which patients are divided into two groups: high risk (5 points)
and low risk (2e4 points); it is mainly for VTE risk assessment in
trauma patients.19 Currently, there are two views on the RAP score
in clinical application. One view is that this score can achieve
effective risk stratiﬁcation for VTE in trauma patients. Supporting
this idea, one study found that the RAP score had a sensitivity of
0.82 and a speciﬁcity of 0.57 in the moderate-risk group, while it
had a sensitivity of 0.15 and a speciﬁcity of 0.97 in the high-risk
group.20 This result indicates that the RAP score is highly corre-
latedwith the risk of VTE in trauma patients and thus is an effective
risk assessment tool. The other view is that this score cannot ach-
ieve effective risk stratiﬁcation of VTE in trauma patients. Sup-
porting this idea, a retrospective study reported three cases of VTE
in 26 low-risk patients and suggested the critical score of 5 points
being invalid. Anticoagulation is recommended for all trauma pa-
tients, unless there is a clear contraindication.21 Although further
investigation is still needed to determine whether the RAP score
can be used as a VTE risk assessment method in trauma patients,
this score presents the relationship between abbreviated injury
scale (AIS) and VTE, while it also proposes transfusion, repair, or
ligation of large blood vessels as a risk factor for VTE, thus providing
a theoretical reference for the prevention of VTE.3.4. Kucher scale
The Kucher scale was published in 2005 and includes eight
common risk factors. These factors are assigned to the following
scores in accordance with the level of risk: malignant tumor, his-
tory of VTE, and hypercoagulable state of blood e 3 points each;
moderate surgery e 2 points; and old age, obesity, bedridden, and
estrogen replacement therapy or oral contraceptives e 1 point
each. When a patient scores 4 points, the risk of developing VTE
increases.22 Kucher combined this scale with a computer infor-
mation system and programmed an early warning procedure for
risk that automatically scores based on relevant information from
patient admission and discharge records. When the total score is
4 points, the computer sends an early warning and reminds
medical personnel of an increased risk of VTE for the patient. This
scale combines with computer systems and performs dynamic
assessment of the risk of VTE in patients. It can remind clinicians
and paramedics of the risk of VTE in patients in a timely manner
and thus greatly reduce the workload of medical staff.
3.5. Padua prediction score
In 2010, Barbar et al23 designed the Padua prediction score by
adding thrombosis-related clinical scenarios based on the Kucher
model. The Padua prediction score includes 11 risk factors: active
cancer, history of VTE, decreased activity, thrombophilia, trauma or
surgery in the last month, old age (70 years), heart/lung failure,
acute myocardial infarction/stroke, acute infection/rheumatic dis-
ease, obesity (BMI30 kg/m2), and ongoing hormone therapy. Each
risk factor is assigned a score of 1e3 points, by which patients are
divided into two levels of risk: low risk (<4 points) and high risk
(4 points) to assess the risk of VTE in internal medicine inpatients.
One study showed that the Padua prediction score is highly asso-
ciated with patients who died from VTE.24 This score was recom-
mended for VTE risk assessment in internal medicine inpatients by
the 2012 American College of Chest Physicians Evidence-Based
Clinical Practice Guidelines for Antithrombotic Therapy and Pre-
vention of Thrombosis.25 The Padua prediction score is character-
ized by the inclusion of heart/lung failure, acute myocardial
infarction/stroke and acute infection/rheumatic disease among the
various thrombotic clinical diseases.23 This focus suggests that
certain special diseases raise the risk of developing VTE. Moreover,
the population previously thought to be at high risk of DVT was
surgical and trauma patients. Caution is needed when evaluating
and intervening for high-risk medical patients.
3.6. The IMPROVE RAM
In 2011, Spyropoulos et al26 reported the IMPROVE RAM that
was developed based on multiple regression analysis of the risk
factors for VTE in 15,156 patients from the International Medical
Prevention Registry on Venous Thromboembolism (IMPROVE).27
The IMPROVE RAM includes seven risk factors: age >60 years,
history of VTE, stay in intensive care unit (ICU) or coronary care unit
(CCU), paralysis of the lower limbs, immobilization, thrombosis
physique, and cancer. Each risk factor is scored 1e3 points, and a
total score 2 is deﬁned as high risk. In 2014, Rosenberg et al28
performed external validation of the IMPROVE RAM in 19,217 pa-
tients. This group yielded an area under the receiver operating
characteristic (ROC) curve of 0.7, and the authors recommended
deﬁning patients with a score of 3 points as the high-risk popu-
lation for VTE. This model was created and validated using large
sample populations. It particularly emphasizes a higher risk of VTE
in the population in the ICU or CCU and warns clinicians to pay
attention to the risk of VTE in critically ill patients.
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To simplify the VTE assessment model and improve the rate of
implementing VTE prevention, Woller et al29 established and
validated the Woller model, which included four risk factors: his-
tory of VTE, bedridden, central venous catheter placement, and
cancer. Compared with the area under the ROC curve (AUC) of the
Kucher score, theWoller model had a greater AUC of 0.843. In 2012,
members of the IMPROVEmodel questioned theWoller model, and
it was noted that the predicted rate of VTE would be exaggerated by
using ICD-9 codes as an outcome measure.30 In the same year,
Woller et al31 responded that the model could be corrected by
changing the risk factors to history of VTE, physician-prescribed
bed rest, central venous catheter placement, and cancer. After
these changes, the AUC of the model was corrected to 0.74.
Meanwhile, Woller et al noted that the risk of VTE in patients is
constantly changing, making it necessary to design dynamic RAMs
and use electronic means to assess the patients. This group also
admitted that further prospective trials are needed to verify the
model's validity, irrespective of the Woller or IMPROVE model.
4. Conclusions
Virchow proposed that the three elements for DVT formation
are impaired blood ﬂow, injured vein wall, and hypercoagulable
state.32 Throughout the history of the development of VTE assess-
ment tools overseas, the risk of VTE has been found to be elevated
not only in surgical and trauma patients. In recent years, there have
also been many studies on VTE risk assessment and intervention in
internal medical patients. Currently, the work on VTE risk assess-
ment in China is still in its initial exploration stage. Although
clinical and healthcare workers have been aware of the importance
of personalized risk assessment and preventive intervention for
VTE in patients, there remains a lack of reliable, effective, and
practical risk assessment tools.33 The risk assessment tools over-
seas are relatively mature; however, owing to the large differences
in race, types of illnesses, lifestyles, and genetic factors, the risk
factors included in foreign scales cannot reﬂect the risk of VTE in
Chinese patients. Therefore, we cannot directly apply these
assessment tools in Chinese patients. It is necessary to build suit-
able personalized RAMs by combining the characteristics of Chi-
nese population.
4.1. Collecting RAM risk factors
According to the content of foreign VTE risk assessment tools,
the following factors are being emphasized: age, gender, medical
history and family history of thrombosis, surgical site, time, chronic
diseases, activity level, risk of bleeding, fractures and trauma, ge-
netic factors, cancer, hormone replacement therapies, blood
transfusion, thrombosis physique, ICU patients,34 mechanical
ventilation, chemotherapy, heart/lung failure, acute myocardial
infarction/stroke, acute infections/rheumatic disease, among other
clinical diseases. In China, research has also found that smoking,35
hypertension,36 diabetes,37 and stroke38 are among the risk factors
inducing VTE. To ensure the completeness and effectiveness of risk
factors, it is critical to collect as much relevant clinical information
and data as possible, with a tendency to prefer objective, reliable
risk indicators.
4.2. Determining a RAM building method
Multi-center, large-sample retrospective studies need to be
conducted in China, which, by learning from the assessment tools
overseas, can use multiple stepwise regression to analyze theclinical data of patients, screen for VTE risk factors, determine their
degree of inﬂuence, divide the corresponding risk levels, and
determine the appropriate prevention methods. Thus, we can ul-
timately build RAMs suitable for Chinese patients, followed by
veriﬁcation of clinical reliability and validity and subsequent clin-
ical validation. Once the RAM is built, optimization analysis needs
to be conducted to improve the rate of implementation of the
model.4.3. Considerations in RAM building
In the course of intervening for patients at risk for VTE, the ﬁrst
thing to consider is the balance between bleeding and anti-
coagulation. Therefore, it is necessary to take into consideration the
risk of bleeding in patients when building RAMs.39 The bleeding
risk score can be developed by referring to foreign bleeding risk
scores40 in combination with the conditions of Chinese patients.4.4. Prospects for RAMs
With the constant development of electronic health information
systems, it will become increasingly preferred by healthcare
workers to program RAMs into specialized medical computer sys-
tems and thereby develop specialized medical tools for risk
assessment for VTE. Such specialized medical tools have multiple
advantages such as easy access to the database and effective,
continuous, dynamic tests, making it possible to balance the risk of
bleeding, timely and dynamic assessment of the risk of VTE in pa-
tients, and implementation of appropriate preventive measures.
Therefore, the construction of VTE RAMs suitable for the national
conditions in China and the further development of these condi-
tions into electronic assessment tools for different populations will
become the future trend in the development of VTE RAMs.Conﬂict of interest
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